PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Research Center, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.\', \'Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.\', \'Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; Department of Pharmacognosy and Biotechnology, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: rkhodarahmi@mbrc.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0188-4409(20)30551-810.1016/j.arcmed.2020.04.018
?:doi
?:hasPublicationType
?:journal
  • Archives of medical research
is ?:pmid of
?:pmid
?:pmid
  • 32387040
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.009
?:rankingScore_hIndex
  • 68
?:title
  • Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32387040>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32387040>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all